These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6147394)

  • 1. Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia.
    Allen JM; Ferrier IN; Roberts GW; Cross AJ; Adrian TE; Crow TJ; Bloom SR
    J Neurol Sci; 1984 Jun; 64(3):325-31. PubMed ID: 6147394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
    Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
    Koshimura K; Kato T; Yohyama I; Nakamura S; Kameyama M
    Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides in Alzheimer type dementia.
    Ferrier IN; Cross AJ; Johnson JA; Roberts GW; Crow TJ; Corsellis JA; Lee YC; O'Shaughnessy D; Adrian TE; McGregor GP
    J Neurol Sci; 1983 Dec; 62(1-3):159-70. PubMed ID: 6199464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.
    Henke H; Lang W
    Brain Res; 1983 May; 267(2):281-91. PubMed ID: 6871677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distribution of neuropeptide Y and its receptor in the porcine central nervous system.
    Busch-Sørensen M; Sheikh SP; O'Hare M; Tortora O; Schwartz TW; Gammeltoft S
    J Neurochem; 1989 May; 52(5):1545-52. PubMed ID: 2540275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glutamatergic innervation of the nucleus basalis/substantia innominata.
    Davies SW; McBean GJ; Roberts PJ
    Neurosci Lett; 1984 Mar; 45(1):105-10. PubMed ID: 6328369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease.
    Foster NL; Tamminga CA; O'Donohue TL; Tanimoto K; Bird ED; Chase TN
    Neurosci Lett; 1986 Jan; 63(1):71-5. PubMed ID: 3754039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
    Armstrong DM; Bruce G; Hersh LB; Terry RD
    Neurosci Lett; 1986 Nov; 71(2):229-34. PubMed ID: 2431362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of large acetylcholinesterase-containing neurons in human neostriatum as disclosed in normal and Alzheimer-diseased brains.
    Parent A; Csonka C; Etienne P
    Brain Res; 1984 Jan; 291(1):154-8. PubMed ID: 6697180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.
    Etienne P; Robitaille Y; Wood P; Gauthier S; Nair NP; Quirion R
    Neuroscience; 1986 Dec; 19(4):1279-91. PubMed ID: 3822122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of neuropeptide Y and somatostatin in Parkinson's disease.
    Allen JM; Cross AJ; Crow TJ; Javoy-Agid F; Agid Y; Bloom SR
    Brain Res; 1985 Jun; 337(1):197-200. PubMed ID: 2860955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of choline acetyltransferase in rabbit forebrain.
    Chao LP; Kan KS; Hung FM
    Brain Res; 1982 Mar; 235(1):65-82. PubMed ID: 6765220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic lesions of the rat brain by ibotenic acid and 192 IgG-saporin: effects on somatostatin, substance P and neuropeptide Y levels in the cerebral cortex and the hippocampus.
    Nag S; Tang F
    Neurosci Lett; 1998 Aug; 252(2):83-6. PubMed ID: 9756327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
    Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
    [No Abstract]   [Full Text] [Related]  

  • 16. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Davies P; Terry RD
    Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations.
    Perry RH; Candy JM; Perry EK; Thompson J; Oakley AE
    J Anat; 1984 Jun; 138 ( Pt 4)(Pt 4):713-32. PubMed ID: 6746407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin: alterations in the central nervous system in neurological diseases.
    Beal MF; Uhl G; Mazurek MF; Kowall N; Martin JB
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():215-57. PubMed ID: 2873636
    [No Abstract]   [Full Text] [Related]  

  • 20. An immunohistochemical study of cathepsin E in Alzheimer-type dementia brains.
    Bernstein HG; Wiederanders B
    Brain Res; 1994 Dec; 667(2):287-90. PubMed ID: 7697369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.